Share story
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Novadip raises €10.4 million to complete pivotal bone-graft trial Image: Primary
Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and European Union for NVD003, a graft made from a patient's own stem cells to treat congenital pseudarthrosis of the tibia, and preparation of a US regulatory submission. Reaching the financing target also opens access to a tranche of an €18 million European Investment Bank venture-debt agreement. Novadip aims for market authorization in 2028, so the product remains in clinical development and is not approved.
Sources
EU-Startups
In this story
European Union
Published by Tech & Business, a media brand covering technology and business. This story was sourced from EU-Startups and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital AI
Capital AI

Mindmax raises $3.3m for conversational AI exam tutor

London startup Mindmax announced $3.3m (£2.5m) in pre-seed funding to build an AI tutor for professional exams and workplace skills. Concept Ventures led the round, joined by Redrice Ventures, Daybreak Ventures and Lerer Hippeau.

The Next Web
Infrastructure Products
Infrastructure Products

Microsoft declines option to expand Nscale Texas data center contract

Microsoft has rejected an option to more than double its Texas data center contract with Nscale, the Financial Times reported, citing sources. The decision is a setback for the startup as it pursues ambitions for a $35B initial public offering.

Techmeme